JPRN-UMIN000019719已完成未知
Estimating the Effects of Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head using Inverse Probability of Treatment Weighting: A Dual-institution Observational Study - NACRT for PDAC
Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine0 个研究点目标入组 504 人开始时间: 2015年11月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 504
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Unresectable pancreatic cancer (NCCN criteria) (2)Tumors with encasement or stenosis of the arteries, those abutted with the celiac axis (3) Hematologic, renal, hepatic and respiratory dysfunction (4)Active infections (5) Severe cardiac disorder, renal disorder, liver disorder, ulcer with bleeding, intestinal tract paralysis, uncontrollable diabetes mellitus (6) Presence of pleural effusion or ascites requiring drainage (7)Pregnant females or nursing mothers who can not stop lactation. Patients or partners, who don't attempt to doing contraception during the study period. (8) Severe mental disorder (9) Severe drug hypersensitivity (10) As determined by the principal investigator or the sub-investigator the subject is not adequate to participate in the trial.
研究者
相似试验
已完成
不适用
Prospective cohort study of neoadjuvant chemoradiotherapy using GEM and nabPTX for borderline resectable pancreatic cancerBorderline resectable pancreatic cancerJPRN-UMIN000018366Department of gastroenterological surgery, Yokohama city university graduate school of medicine100
招募中
2 期
Effect of chemoradiotherapy on locally advanced cancer of CardiaIRCT20140203016473N12Tabriz University of Medical Sciences60
已完成
不适用
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.JPRN-UMIN000046338Sapporo Medical University24
招募中
不适用
Prospective study of neoadjuvant chemotherapy with FEC100x4 for BRCAness cases in triple negative breast cancerBreast cancerJPRN-UMIN000029433Tokyo medical university70
尚未招募
不适用
Prediction of response to Neoadjuvant chemotherapy(bi-weeklyS1/Docetaxel therapy) in advanced gastric cancerGastric cancerJPRN-UMIN000011521Yokohama City University School of Medicine Department of Gastroenterological Surgery50